MetLife Investment Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.3M Sell
117,687
-761
-0.6% -$66.4K 0.06% 307
2025
Q1
$8.09M Sell
118,448
-2,119
-2% -$145K 0.04% 410
2024
Q4
$9.38M Sell
120,567
-1,844
-2% -$143K 0.05% 278
2024
Q3
$8.21M Sell
122,411
-1,967
-2% -$132K 0.05% 310
2024
Q2
$14.1M Buy
124,378
+18,102
+17% +$2.05M 0.08% 174
2024
Q1
$14.7M Sell
106,276
-3,456
-3% -$479K 0.1% 160
2023
Q4
$13.6M Sell
109,732
-2,291
-2% -$284K 0.1% 161
2023
Q3
$10.5M Sell
112,023
-2,454
-2% -$229K 0.08% 193
2023
Q2
$14.7M Sell
114,477
-597
-0.5% -$76.7K 0.11% 143
2023
Q1
$13.4M Sell
115,074
-1,120
-1% -$130K 0.1% 156
2022
Q4
$13.2M Sell
116,194
-4,238
-4% -$480K 0.1% 157
2022
Q3
$9.7M Sell
120,432
-1,321
-1% -$106K 0.08% 202
2022
Q2
$9.07M Sell
121,753
-939
-0.8% -$70K 0.07% 221
2022
Q1
$15.7M Buy
122,692
+37,032
+43% +$4.74M 0.1% 156
2021
Q4
$11.5M Sell
85,660
-1,752
-2% -$235K 0.09% 167
2021
Q3
$12M Sell
87,412
-2,272
-3% -$311K 0.11% 151
2021
Q2
$9.57M Sell
89,684
-1,992
-2% -$213K 0.08% 195
2021
Q1
$8.24M Sell
91,676
-1,608
-2% -$144K 0.08% 229
2020
Q4
$8.62M Sell
93,284
-3,816
-4% -$353K 0.08% 197
2020
Q3
$10M Buy
97,100
+536
+0.6% +$55.2K 0.11% 159
2020
Q2
$9.79M Buy
+96,564
New +$9.79M 0.11% 160
2019
Q2
Sell
-480
Closed -$14.3K 2472
2019
Q1
$14.3K Buy
480
+4
+0.8% +$119 ﹤0.01% 2359
2018
Q4
$14.3K Sell
476
-4
-0.8% -$120 ﹤0.01% 2353
2018
Q3
$17.2K Buy
+480
New +$17.2K ﹤0.01% 2395